Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
fda
indiana blog main
indiana top stories
ipo
3
×
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
novartis
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
asklepios biopharmaceutical
biogen
cancer
crispr
crispr therapeutics
medical devices
startups
vc
venture capital
2025
What
bio
3
×
new
3
×
roundup
ipo
activity
allogene
approvals
bails
biogen
brand
bridgebio
cancer
capital
car
clamped
covid
crispr
delays
develop
developing
diversity
drugs
economic
emerges
fast
fda
firm
grab
headlines
hot
ichnos
immunotherapy
including
invest
investors
isn’t
juno
life
lot
medicines
Language
unset
Current search:
ipo
×
new
×
bio
×
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More
